Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies.

Marrella A, Dondero A, Aiello M, Casu B, Olive D, Regis S, Bottino C, Pende D, Meazza R, Caluori G, Castriconi R, Scaglione S.

Front Immunol. 2019 Aug 9;10:1876. doi: 10.3389/fimmu.2019.01876. eCollection 2019.

2.

Novel Immunoregulatory Functions of IL-18, an Accomplice of TGF-β1.

Casu B, Dondero A, Regis S, Caliendo F, Petretto A, Bartolucci M, Bellora F, Bottino C, Castriconi R.

Cancers (Basel). 2019 Jan 11;11(1). pii: E75. doi: 10.3390/cancers11010075.

3.

Molecular Mechanisms Directing Migration and Retention of Natural Killer Cells in Human Tissues.

Castriconi R, Carrega P, Dondero A, Bellora F, Casu B, Regis S, Ferlazzo G, Bottino C.

Front Immunol. 2018 Oct 11;9:2324. doi: 10.3389/fimmu.2018.02324. eCollection 2018. Review.

4.

Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma.

Morandi F, Amoroso L, Dondero A, Castriconi R, Parodi S, Luksch R, Casale F, Castellano A, Garaventa A, Moretta A, Bottino C, Ponzoni M, Corrias MV.

Oncoimmunology. 2018 Jul 30;7(9):e1468953. doi: 10.1080/2162402X.2018.1468953. eCollection 2018.

5.

TGF-β1 Downregulates the Expression of CX3CR1 by Inducing miR-27a-5p in Primary Human NK Cells.

Regis S, Caliendo F, Dondero A, Casu B, Romano F, Loiacono F, Moretta A, Bottino C, Castriconi R.

Front Immunol. 2017 Jul 25;8:868. doi: 10.3389/fimmu.2017.00868. eCollection 2017.

6.

Imatinib and Nilotinib Off-Target Effects on Human NK Cells, Monocytes, and M2 Macrophages.

Bellora F, Dondero A, Corrias MV, Casu B, Regis S, Caliendo F, Moretta A, Cazzola M, Elena C, Vinti L, Locatelli F, Bottino C, Castriconi R.

J Immunol. 2017 Aug 15;199(4):1516-1525. doi: 10.4049/jimmunol.1601695. Epub 2017 Jul 12.

7.

NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27.

Dondero A, Casu B, Bellora F, Vacca A, De Luisi A, Frassanito MA, Cantoni C, Gaggero S, Olive D, Moretta A, Bottino C, Castriconi R.

Oncotarget. 2017 May 23;8(21):35088-35102. doi: 10.18632/oncotarget.17070.

8.

PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance.

Dondero A, Pastorino F, Della Chiesa M, Corrias MV, Morandi F, Pistoia V, Olive D, Bellora F, Locatelli F, Castellano A, Moretta L, Moretta A, Bottino C, Castriconi R.

Oncoimmunology. 2015 Jul 15;5(1):e1064578. eCollection 2016.

9.

Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approaches.

Bottino C, Dondero A, Bellora F, Moretta L, Locatelli F, Pistoia V, Moretta A, Castriconi R.

Front Immunol. 2014 Feb 12;5:56. doi: 10.3389/fimmu.2014.00056. eCollection 2014. Review.

10.

TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells.

Bellora F, Castriconi R, Dondero A, Pessino A, Nencioni A, Liggieri G, Moretta L, Mantovani A, Moretta A, Bottino C.

Eur J Immunol. 2014 Jun;44(6):1814-22. doi: 10.1002/eji.201344130. Epub 2014 Mar 6.

11.

Human NK cells and NK receptors.

Bellora F, Castriconi R, Dondero A, Carrega P, Mantovani A, Ferlazzo G, Moretta A, Bottino C.

Immunol Lett. 2014 Oct;161(2):168-73. doi: 10.1016/j.imlet.2013.12.009. Epub 2013 Dec 19. Review.

PMID:
24361820
12.

Neuroblastoma-derived TGF-β1 modulates the chemokine receptor repertoire of human resting NK cells.

Castriconi R, Dondero A, Bellora F, Moretta L, Castellano A, Locatelli F, Corrias MV, Moretta A, Bottino C.

J Immunol. 2013 May 15;190(10):5321-8. doi: 10.4049/jimmunol.1202693. Epub 2013 Apr 10.

13.

Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells.

Morandi F, Ferretti E, Castriconi R, Dondero A, Petretto A, Bottino C, Pistoia V.

Blood. 2011 Nov 24;118(22):5840-50. doi: 10.1182/blood-2011-05-352393. Epub 2011 Oct 11.

14.

The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes.

Bellora F, Castriconi R, Dondero A, Reggiardo G, Moretta L, Mantovani A, Moretta A, Bottino C.

Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21659-64. doi: 10.1073/pnas.1007654108. Epub 2010 Nov 30.

15.

NK cells recognize and kill human glioblastoma cells with stem cell-like properties.

Castriconi R, Daga A, Dondero A, Zona G, Poliani PL, Melotti A, Griffero F, Marubbi D, Spaziante R, Bellora F, Moretta L, Moretta A, Corte G, Bottino C.

J Immunol. 2009 Mar 15;182(6):3530-9. doi: 10.4049/jimmunol.0802845.

16.

Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule.

Gregorio A, Corrias MV, Castriconi R, Dondero A, Mosconi M, Gambini C, Moretta A, Moretta L, Bottino C.

Histopathology. 2008 Jul;53(1):73-80. doi: 10.1111/j.1365-2559.2008.03070.x.

17.

Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity.

Castriconi R, Dondero A, Negri F, Bellora F, Nozza P, Carnemolla B, Raso A, Moretta L, Moretta A, Bottino C.

Eur J Immunol. 2007 Nov;37(11):3190-6.

18.

Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice.

Castriconi R, Dondero A, Cilli M, Ognio E, Pezzolo A, De Giovanni B, Gambini C, Pistoia V, Moretta L, Moretta A, Corrias MV.

Cancer Immunol Immunother. 2007 Nov;56(11):1733-42. Epub 2007 Apr 11.

PMID:
17426969
19.

Functional characterization of natural killer cells in type I leukocyte adhesion deficiency.

Castriconi R, Dondero A, Cantoni C, Della Chiesa M, Prato C, Nanni M, Fiorini M, Notarangelo L, Parolini S, Moretta L, Notarangelo L, Moretta A, Bottino C.

Blood. 2007 Jun 1;109(11):4873-81. Epub 2007 Feb 1.

20.

It's only innate immunity but I like it.

Marcenaro E, Della Chiesa M, Dondero A, Ferranti B, Moretta A.

Adv Exp Med Biol. 2007;590:89-101. Review. No abstract available.

PMID:
17191379
21.

Multi-directional cross-regulation of NK cell function during innate immune responses.

Marcenaro E, Dondero A, Moretta A.

Transpl Immunol. 2006 Dec;17(1):16-9. Epub 2006 Oct 10. Review.

PMID:
17157207
22.

Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction.

Pende D, Castriconi R, Romagnani P, Spaggiari GM, Marcenaro S, Dondero A, Lazzeri E, Lasagni L, Martini S, Rivera P, Capobianco A, Moretta L, Moretta A, Bottino C.

Blood. 2006 Mar 1;107(5):2030-6. Epub 2005 Nov 22.

23.

PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.

Pende D, Bottino C, Castriconi R, Cantoni C, Marcenaro S, Rivera P, Spaggiari GM, Dondero A, Carnemolla B, Reymond N, Mingari MC, Lopez M, Moretta L, Moretta A.

Mol Immunol. 2005 Feb;42(4):463-9.

PMID:
15607800
24.

Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction.

Castriconi R, Dondero A, Corrias MV, Lanino E, Pende D, Moretta L, Bottino C, Moretta A.

Cancer Res. 2004 Dec 15;64(24):9180-4.

25.

Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis.

Castriconi R, Dondero A, Augugliaro R, Cantoni C, Carnemolla B, Sementa AR, Negri F, Conte R, Corrias MV, Moretta L, Moretta A, Bottino C.

Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12640-5. Epub 2004 Aug 16.

26.

Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.

André P, Castriconi R, Espéli M, Anfossi N, Juarez T, Hue S, Conway H, Romagné F, Dondero A, Nanni M, Caillat-Zucman S, Raulet DH, Bottino C, Vivier E, Moretta A, Paul P.

Eur J Immunol. 2004 Apr;34(4):961-71.

27.

IFN-gamma production in human NK cells through the engagement of CD8 by soluble or surface HLA class I molecules.

Spaggiari GM, Contini P, Negrini S, Dondero A, Carosio R, Ghio M, Puppo F, Indiveri F, Zocchi MR, Poggi A.

Eur J Immunol. 2003 Nov;33(11):3049-59.

28.

Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction.

Spaggiari GM, Contini P, Dondero A, Carosio R, Puppo F, Indiveri F, Zocchi MR, Poggi A.

Blood. 2002 Dec 1;100(12):4098-107. Epub 2002 Jul 18.

29.

Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily.

Spaggiari GM, Contini P, Carosio R, Arvigo M, Ghio M, Oddone D, Dondero A, Zocchi MR, Puppo F, Indiveri F, Poggi A.

Blood. 2002 Mar 1;99(5):1706-14.

30.

Critical flicker frequency in light- and dark-adaptation.

DONDERO A, HOFSTAETTER PR, O'CONNOR JP.

J Gen Psychol. 1958 Jan;58(1):11-6. No abstract available.

PMID:
13481336
31.

Critical flicker frequency and cortical alpha.

DONDERO A, HOFSTAETTER PR, O'CONNOR JP.

Electroencephalogr Clin Neurophysiol. 1956 Aug;8(3):465-6. No abstract available.

PMID:
13330658

Supplemental Content

Loading ...
Support Center